132 related articles for article (PubMed ID: 7666614)
1. [Augmentation of immune defense mechanisms of the lung by romurtide].
Hasegawa J; Satoh A; Yagi K; Chida K
Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Jun; 33(6):605-11. PubMed ID: 7666614
[TBL] [Abstract][Full Text] [Related]
2. [Role of alveolar macrophages and neutrophils in the defense system against infection of Pseudomonas aeruginosa in the respiratory tract and the effect of derivative of muramyl dipeptide].
Maeda M; Ozaki T; Yasuoka S; Ogura T
Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Jan; 28(1):135-42. PubMed ID: 2355674
[TBL] [Abstract][Full Text] [Related]
3. Stimulatory effect of romurtide on hematopoiesis in monkeys.
Nakajima R; Yshida Y; Akahane K; Sekiguchi M; Osada Y
Arzneimittelforschung; 1991 Jan; 41(1):60-5. PubMed ID: 2049113
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of non-specific resistance to infection by muroctasin.
Otani T; Une T; Osada Y
Arzneimittelforschung; 1988 Jul; 38(7A):969-76. PubMed ID: 3056426
[TBL] [Abstract][Full Text] [Related]
5. Augmentation by priming with interferon-gamma of the binding of a muramyl dipeptide derivative to macrophages resulting in synergistic macrophage activation.
Nagao S; Sato K; Osada Y
Jpn J Cancer Res; 1987 Jan; 78(1):80-6. PubMed ID: 3102442
[TBL] [Abstract][Full Text] [Related]
6. Role of alveolar macrophages in the neutrophil-dependent defense system against Pseudomonas aeruginosa infection in the lower respiratory tract. Amplifying effect of muramyl dipeptide analog.
Ozaki T; Maeda M; Hayashi H; Nakamura Y; Moriguchi H; Kamei T; Yasuoka S; Ogura T
Am Rev Respir Dis; 1989 Dec; 140(6):1595-601. PubMed ID: 2513762
[TBL] [Abstract][Full Text] [Related]
7. Acute and chronic polyarthritis induced by an aqueous form of 6-O-acyl and N-acyl derivatives of N-acetylmuramyl-L-alanyl-D-isoglutamine in euthymic rats and athymic nude rats.
Kohashi O; Kohashi Y; Shigematsu N; Ozawa A; Kotani S
Lab Invest; 1986 Sep; 55(3):337-46. PubMed ID: 3489128
[TBL] [Abstract][Full Text] [Related]
8. Review: inducer of cytokines in vivo: overview of field and romurtide experience.
Azuma I
Int J Immunopharmacol; 1992 Apr; 14(3):487-96. PubMed ID: 1618600
[TBL] [Abstract][Full Text] [Related]
9. Muramyl dipeptide-Lys stimulates the function of human dendritic cells.
Todate A; Suda T; Kuwata H; Chida K; Nakamura H
J Leukoc Biol; 2001 Nov; 70(5):723-9. PubMed ID: 11698491
[TBL] [Abstract][Full Text] [Related]
10. [Muramyl dipeptide derivative and its clinical application].
Tsubura E
Kekkaku; 1989 Nov; 64(11):731-9. PubMed ID: 2593464
[TBL] [Abstract][Full Text] [Related]
11. Differences in interleukin 1 (IL-1), IL-6, tumor necrosis factor and IL-1 receptor antagonist production by human monocytes stimulated with muramyl dipeptide (MDP) and its stearoyl derivative, romurtide.
Suzuki K; Torii K; Hida S; Hayashi H; Hiyama Y; Oomoto Y; Takii T; Chiba T; Onozaki K
Immunopharmacology; 1994; 28(1):31-8. PubMed ID: 7928300
[TBL] [Abstract][Full Text] [Related]
12. Production of interleukin-6 from macrophages by MDP-Lys (L 18), romurtide.
Shimoda K; Okamura S; Harada N; Omori F; Niho Y
Res Commun Chem Pathol Pharmacol; 1990 Dec; 70(3):289-96. PubMed ID: 2093210
[TBL] [Abstract][Full Text] [Related]
13. Activation of alveolar macrophage tumoricidal activity and eradication of experimental metastases by freeze-dried liposomes containing a new lipophilic muramyl dipeptide derivative.
Phillips NC; Moras ML; Chedid L; Lefrancier P; Bernard JM
Cancer Res; 1985 Jan; 45(1):128-34. PubMed ID: 3838084
[TBL] [Abstract][Full Text] [Related]
14. Experimental and clinical studies on the effects of synthetic muramyldipeptide derivatives on viral and opportunistic infections.
Yamamura Y; Ishihara C; Hamada N; Yamamoto K; Azuma I
Methods Find Exp Clin Pharmacol; 1986 Jan; 8(1):11-4. PubMed ID: 3010013
[TBL] [Abstract][Full Text] [Related]
15. Activation of immune responses by muroctasin.
Akasaki M
Arzneimittelforschung; 1988 Jul; 38(7A):976-7. PubMed ID: 3056427
[TBL] [Abstract][Full Text] [Related]
16. Effect of MDP-Lys(L18), a derivative of MDP, on enhancing host resistance against Hantaan virus infection in newborn mice.
Yoo YC; Yoshimatsu K; Hatsuse R; Tamura M; Yoshida R; Tono-oka S; Arikawa J; Azuma I
Vaccine; 1995 Oct; 13(14):1300-5. PubMed ID: 8585284
[TBL] [Abstract][Full Text] [Related]
17. Effect of muramyl dipeptide and its stearoyl derivatives on resistance to Sendai virus infection in mice.
Ishihara C; Hamada N; Yamamoto K; Iida J; Azuma I; Yamamura Y
Vaccine; 1985 Dec; 3(5):370-4. PubMed ID: 2417426
[TBL] [Abstract][Full Text] [Related]
18. Synergistic effect of romurtide with ampicillin against pneumococcal pneumonia in mice.
Nakajima R; Namba K; Ishida Y; Katsuma E; Otani T; Osada Y
Chemotherapy; 1992; 38(4):238-50. PubMed ID: 1473363
[TBL] [Abstract][Full Text] [Related]
19. Intrapleural therapy with MDP-Lys (L18), a synthetic derivative of muramyl dipeptide, against malignant pleurisy associated with lung cancer.
Yanagawa H; Haku T; Takeuchi E; Suzuki Y; Nokihara H; Sone S
Lung Cancer; 2000 Feb; 27(2):67-73. PubMed ID: 10688489
[TBL] [Abstract][Full Text] [Related]
20. [Muroctasin, a muramyl dipeptide derivative].
Sosnowska D; Dzierzbicka K; Myśliwski A; Kołodziejczyk AM
Postepy Hig Med Dosw; 1992; 46(5):521-30. PubMed ID: 1298958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
